Walmart adds 250 free medicines: Mizuho cuts target for Walmart stock

Published on 10/14/2026 at 13:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fiscal Q2 revenue rose 5.90 percent to USD 187.94 billion. Walmart stock costs EUR 100.88 on October 14, 2026, versus EUR 101.66.

Benefits and valuation signals

Walmart introduced more than 250 no-cost medicines for employees on October 13, 2026.
Fiscal second-quarter revenue reached USD 187.94 billion, up 5.90 percent year over year.
Walmart stock was trading at EUR 100.88 at 1:31 p.m. CEST on October 14, 2026, 0.77 percent below the Xetra close of October 13, 2026.
Mizuho cut its target from USD 130.00 to USD 125.00 on September 29, 2026.

Redaktionelle Illustration des belebten NYSE-Börsenparkettsaals mit Händlern in farbigen Jacken und elektronischen Kurstafeln — Walmart US9311421039 NYSE Börsen Editorial mit Händlern in farbigen Jacken am lebhaften Handelsparkett, Illustration mit AI erstellt.

Walmart (ISIN US9311421039) introduced a benefits package covering more than 250 prescription medicines at no cost for eligible U.S. employees on October 13, 2026. The announcement arrived as Reuters reported the plan and as Mizuho lowered its price target from USD 130.00 to USD 125.00 while retaining an Outperform rating, according to Stocktwits on September 29, 2026.

Benefits begin in January

Walmart said the new Zero Dollar prescription tier will start January 1, 2027 and include generic, brand-name and specialty medicines, including some insulin products and inhalers. The company also announced no-cost specialist access for certain rare conditions and up to 12 weeks of paid neonatal intensive care leave beginning November 17, 2026, per Walmart.

Three dated developments

On August 20, 2026, Walmart reported fiscal second-quarter revenue of USD 187.94 billion, up 5.90 percent year over year, while adjusted earnings per share reached USD 0.81 against a USD 0.73 consensus estimate, according to Zacks. On September 29, 2026, Mizuho reduced its target from USD 130.00 to USD 125.00. On October 13, 2026, Walmart announced coverage for more than 250 medicines.

What does the next date test?

Walmart's fiscal third-quarter report is scheduled for November 19, 2026, according to FrontierPicks. Management's fiscal third-quarter guide calls for adjusted earnings per share of USD 0.62 to USD 0.64 and adjusted operating income growth of 2.00 percent to 4.00 percent, while the full-year adjusted earnings-per-share range stands at USD 2.80 to USD 2.87. The contrast matters because fiscal second-quarter adjusted operating income rose 17.40 percent at constant currency, while higher health-care, fuel and depreciation costs remain part of the near-term calculation.

Walmart stock stays below the Xetra close

Walmart was trading at EUR 100.88 at Lang & Schwarz on October 14, 2026 at 1:31 p.m. CEST, 0.77 percent below the Xetra close of October 13, 2026 at EUR 101.66. The current quote sits alongside a USD 893.5 billion market capitalization and a USD 98.88 to USD 135.16 52-week range as of October 13, 2026.

The further course of trading is shown by the continuously updated real-time quote of Walmart stock.